SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-257701
Filing Date
2023-10-17
Accepted
2023-10-17 16:32:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d556499ddefa14a.htm DEFA14A 164798
2 GRAPHIC g556499g1017203220813.jpg GRAPHIC 4074
3 GRAPHIC g556499g1017203221126.jpg GRAPHIC 25767
4 GRAPHIC g556499g1017203221293.jpg GRAPHIC 34566
  Complete submission text file 0001193125-23-257701.txt   255055
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38722 | Film No.: 231329953
SIC: 2836 Biological Products, (No Diagnostic Substances)